{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:30:09Z","timestamp":1784413809434,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40199-019-00266-3","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T23:52:06Z","timestamp":1557964326000},"page":"423-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials"],"prefix":"10.1007","volume":"27","author":[{"given":"Masumeh","family":"Ghazanfarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Najaf","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasibeh","family":"Roozbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadghasem Etemadi","family":"Mashhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Keramat-roudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e9garbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mobin Miri","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-6142","authenticated-orcid":false,"given":"Ramin","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"issue":"2","key":"266_CR1","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1542\/peds.2014-2377","volume":"135","author":"HS Bada","year":"2015","unstructured":"Bada HS, Sithisarn T, Gibson J, Garlitz K, Caldwell R, Capilouto G, et al. Morphine versus clonidine for neonatal abstinence syndrome. Pediatrics. 2015;135(2):e383\u201391.","journal-title":"Pediatrics."},{"issue":"5","key":"266_CR2","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1542\/peds.2008-0978","volume":"123","author":"AG Agthe","year":"2009","unstructured":"Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123(5):e849\u201356.","journal-title":"Pediatrics"},{"issue":"3","key":"266_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/acu.2011.0818","volume":"23","author":"L Schwartz","year":"2011","unstructured":"Schwartz L, Xiao R, Brown ER, Sommers E. Auricular acupressure augmentation of standard medical management of the neonatal narcotic abstinence syndrome. Med Acupunct. 2011;23(3):175\u201386.","journal-title":"Med Acupunct"},{"issue":"1","key":"266_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cct.2014.08.009","volume":"39","author":"T Winhusen","year":"2014","unstructured":"Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, et al. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Contemp Clin Trials. 2014;39(1):158\u201365.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"266_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"8","key":"266_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","volume":"172","author":"JM Davis","year":"2018","unstructured":"Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, et al. Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial. JAMA Pediatr. 2018;172(8):741\u20138.","journal-title":"JAMA Pediatr"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","volume":"376","author":"WK Kraft","year":"2017","unstructured":"Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. N Engl J Med. 2017;376:2341\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"266_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12887-015-0377-9","volume":"15","author":"F Nayeri","year":"2015","unstructured":"Nayeri F, Sheikh M, Kalani M, Niknafs P, Shariat M, Dalili H, et al. Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial. BMC Pediatr. 2015;15(1):15.","journal-title":"BMC Pediatr"},{"issue":"4","key":"266_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","volume":"35","author":"MS Brown","year":"2014","unstructured":"Brown MS, Hayes MJ, Thornton LM. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol. 2014;35(4):278\u201383.","journal-title":"J Perinatol"},{"issue":"12","key":"266_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jp.2013.95","volume":"33","author":"B Surran","year":"2013","unstructured":"Surran B, Visintainer P, Chamberlain S, Kopcza K, Shah B, Singh R. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial. J Perinatol. 2013;33(12):954\u20139.","journal-title":"J Perinatol"},{"issue":"3","key":"266_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","volume":"106","author":"WK Kraft","year":"2011","unstructured":"Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. J Addict. 2011;106(3):574\u201380.","journal-title":"J Addict"},{"issue":"3","key":"266_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1542\/peds.2008-0571","volume":"122","author":"WK Kraft","year":"2008","unstructured":"Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008;122(3):601\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"266_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.07.001","volume":"77","author":"S Langenfeld","year":"2005","unstructured":"Langenfeld S, Birkenfeld L, Herkenrath P, M\u00fcller C, Hellmich M, Theisohn M. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend. 2005;77(1):31\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"90","key":"266_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/adc.2003.046276","volume":"1","author":"MG Coyle","year":"2005","unstructured":"Coyle MG, Ferguson A, Lagasse L, Liu J, Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed. 2005;1(90):73\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"266_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/adc.2003.033555","volume":"89","author":"L Jackson","year":"2004","unstructured":"Jackson L, Ting A, McKay S, Galea P, Skeoch C. A randomized controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):300\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"266_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1067\/mpd.2002.123099","volume":"140","author":"MG Coyle","year":"2002","unstructured":"Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J.Pediatr. 2002;140(5):561\u20134.","journal-title":"J.Pediatr."},{"issue":"3","key":"266_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1046\/j.1460-9568.1999.00488.x","volume":"11","author":"M Diana","year":"1999","unstructured":"Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci. 1999;11(3):1037\u201341.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"266_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1258\/la.2007.06002e","volume":"42","author":"N-G Ilb\u00e4ck","year":"2008","unstructured":"Ilb\u00e4ck N-G, Siller M, St\u00e5lhandske T. Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats. Lab Anim. 2008;42(2):149\u201360.","journal-title":"Lab Anim"},{"issue":"12","key":"266_CR19","first-page":"29","volume":"2","author":"C Welsh","year":"2005","unstructured":"Welsh C, Valadez-Meltzer A. Buprenorphine: a (relatively) new treatment for opioid dependence. Psychiatry (Edgmont). 2005;2(12):29.","journal-title":"Psychiatry (Edgmont)"},{"key":"266_CR20","unstructured":"National Center for Biotechnology Information. PubChem Compound Database; CID=644073, \n                    https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/644073\n                    \n                  . Accessed 1 Nov 2018."},{"issue":"5","key":"266_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000492616","volume":"27","author":"M Behzadi","year":"2018","unstructured":"Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Med Princ Pract. 2018;27(5):401\u201314.","journal-title":"Med Princ Pract"},{"issue":"12","key":"266_CR22","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.xphs.2018.08.025","volume":"107","author":"DA Volpe","year":"2018","unstructured":"Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V. Methadone metabolism and drug-drug interactions: in vitro and in vivo literature review. J Pharm Sci. 2018;107(12):2983\u201391.","journal-title":"J Pharm Sci"},{"issue":"4","key":"266_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/ADM.0b013e3181c4e27e","volume":"4","author":"MP Bogenschutz","year":"2010","unstructured":"Bogenschutz MP, Abbott PJ, Kushner R, Tonigan JS, Woody GE. Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults. J Addict Med. 2010;4(4):211\u20136.","journal-title":"J Addict Med"},{"issue":"949","key":"266_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","volume":"80","author":"R Brown","year":"2004","unstructured":"Brown R, Kraus C, Fleming M, Reddy S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004;80(949):654\u20139.","journal-title":"Postgrad Med J"},{"issue":"4","key":"266_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1213\/ane.0b013e3181823efb","volume":"107","author":"D Hong","year":"2008","unstructured":"Hong D, Flood P, Diaz G. The side effects of morphine and hydromorphone patient-controlled analgesia. Anesth Analg. 2008;107(4):1384\u20139.","journal-title":"Anesth Analg"},{"key":"266_CR26","unstructured":"National Center for Biotechnology Information. PubChem Compound Database; CID=5288826, \n                    https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5288826\n                    \n                  .. Accessed 1 Nov 2018."},{"issue":"6","key":"266_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/104990910302000608","volume":"20","author":"GR Wilson","year":"2003","unstructured":"Wilson GR, Reisfield GM. Morphine hyperalgesia: a case report. Am J Hosp Palliat Care. 2003;20(6):459\u201361.","journal-title":"Am J Hosp Palliat Care"},{"issue":"3","key":"266_CR28","first-page":"159","volume":"37","author":"C Shen","year":"1999","unstructured":"Shen C, Hung C, Wu C, Huang H, Ho W. Rhabdomyolysis-induced acute renal failure after morphine overdose--a case report. Acta Anaesthesiol Sin. 1999;37(3):159\u201362.","journal-title":"Acta Anaesthesiol Sin"},{"key":"266_CR29","unstructured":"Lewis CB, Adams N. Phenobarbital. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Jan 2018. Available at \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532277\n                    \n                  . Accessed 1 Nov 2018."},{"issue":"2\u20133","key":"266_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/j.1552-4604.1982.tb02662.x","volume":"22","author":"E Nelson","year":"1982","unstructured":"Nelson E, Powell JR, Conrad K, Likes K, Byers J, Baker S, et al. Phenobarbital pharmacokinetics and bioavailability in adults. J Clin Pharmacol. 1982;22(2\u20133):141\u20138.","journal-title":"J Clin Pharmacol"},{"key":"266_CR31","unstructured":"National Center for Biotechnology Information. PubChem Compound Database; CID=4763, \n                    https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/4763\n                    \n                  . Accessed 1 Nov 2018."},{"key":"266_CR32","unstructured":"National Center for Biotechnology Information. PubChem Compound Database; CID=2803, \n                    https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2803\n                    \n                  . Accessed 1 Nov 2018."},{"issue":"5","key":"266_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003088-198814050-00002","volume":"14","author":"D Lowenthal","year":"1988","unstructured":"Lowenthal D, Matzek K, MacGregor T. Clinical pharmacokinetics of clonidine. Clin Pharmacokinet. 1988;14(5):287\u2013310.","journal-title":"Clin Pharmacokinet"},{"key":"266_CR34","unstructured":"Chiu S, Campbell K. Clonidine for the treatment of psychiatric conditions and symptoms: a review of clinical effectiveness, safety, and guidelines [internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb 21. Available at \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531717\n                    \n                  . Accessed 1 Nov 2018."},{"issue":"8","key":"266_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jcph.696","volume":"56","author":"T Liu","year":"2016","unstructured":"Liu T, Lewis T, Gauda E, Gobburu J, Ivaturi V. Mechanistic population pharmacokinetics of morphine in neonates with abstinence syndrome after oral administration of diluted tincture of opium. J Clin Pharmacol. 2016;56(8):1009\u201318.","journal-title":"J Clin Pharmacol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40199-019-00266-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:19:59Z","timestamp":1589411999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40199-019-00266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1007\/s40199-019-00266-3","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}